Nabha Sanaa M, Mohammad Ramzi M, Dandashi Mahmoud H, Coupaye-Gerard Brigitte, Aboukameel Amro, Pettit George R, Al-Katib Ayad M
Division of Hematology and Oncology, Department of Internal Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Clin Cancer Res. 2002 Aug;8(8):2735-41.
We have previously reported that combretastatin-A4 prodrug (CA4P), anantitubulin/antiangiogenic agent isolated from the South African willow tree Combretum caffrum, induced cell death primarily through mitotic catastrophe in a panel of human B-lymphoid tumors. In this study, we investigated the molecular aspects of the mitotic catastrophe and whether or not it shares the same pathways of apoptosis. For this we studied the effect of CA4P on selected markers of apoptosis [caspases 9 and 3, poly(ADP-ribose) polymerase (PARP), bcl-2, and bax] and G2-M protein regulators (p53, MDM2, 14-3-3sigma, GADD45, cdc2, cdc25, chk1, wee1, p21, and cyclin B1). The chronic lymphocytic leukemia cell line WSU-CLL was used for this purpose. Western blot analysis showed that 24 h of CA4P (5 nM) exposure induces caspase 9 activation and PARP cleavage. However, the addition of Z-Val-Ala-Asp-fluoromethylketone (a general caspase inhibitor) or Z-Leu-Glu(OMe)-His-Asp(OMe)-CH2F (a caspase 9 inhibitor) before CA4P treatment did not block cell death. No change in bcl-2 or bax protein expression was observed. Exposure of WSU-CLL cells to 4 and 5 nM CA4P was associated with overproduction of total p53 and no dramatic change in MDM2, 14-3-3sigma, GADD45, the cyclin-dependent kinase cdc2, its inhibitory phosphorylation, the cdc2-inhibitory kinase (wee1), chk1, or cdc25 hyperphosphorylation. The overaccumulation of p21 and cyclin B1 protein was obvious at 24 h. Furthermore, CA4P treatment showed an increase in the expression of a marker of mitosis (mitotic protein monoclonal-2 antibody) and an overaccumulation of the cyclin B in the nucleus. Our findings suggest that CA4P induces mitotic catastrophe and arrest of WSU-CLL cells mostly in the M phase independent of p53 and independent of chk1 and cdc2 phosphorylation pathways. Apoptosis is a secondary mechanism of death in a small proportion of cells through activation of caspase 9 and PARP cleavage. The two mechanisms of cell death, i.e., mitotic catastrophe and apoptosis, are independent of each other in our model.
我们之前报道过,从南非柳树 Combretum caffrum 中分离得到的抗微管蛋白/抗血管生成剂考布他汀 A4 前药(CA4P),在一组人类 B 淋巴细胞肿瘤中主要通过有丝分裂灾难诱导细胞死亡。在本研究中,我们调查了有丝分裂灾难的分子层面以及它是否与凋亡共享相同的途径。为此,我们研究了 CA4P 对凋亡相关选定标志物[半胱天冬酶 9 和 3、聚(ADP - 核糖)聚合酶(PARP)、bcl - 2 和 bax]以及 G2 - M 期蛋白调节因子(p53、MDM2、14 - 3 - 3σ、GADD45、cdc2、cdc25、chk1、wee1、p21 和细胞周期蛋白 B1)的影响。慢性淋巴细胞白血病细胞系 WSU - CLL 被用于此目的。蛋白质印迹分析表明,暴露于 5 nM 的 CA4P 24 小时可诱导半胱天冬酶 9 激活和 PARP 裂解。然而,在 CA4P 处理前添加 Z - Val - Ala - Asp - 氟甲基酮(一种通用的半胱天冬酶抑制剂)或 Z - Leu - Glu(OMe)-His - Asp(OMe)-CH2F(一种半胱天冬酶 9 抑制剂)并不能阻断细胞死亡。未观察到 bcl - 2 或 bax 蛋白表达的变化。将 WSU - CLL 细胞暴露于 4 和 5 nM 的 CA4P 与总 p53 的过量产生相关,而 MDM2、14 - 3 - 3σ、GADD45、细胞周期蛋白依赖性激酶 cdc2、其抑制性磷酸化、cdc2 抑制激酶(wee1)、chk1 或 cdc25 的过度磷酸化均无显著变化。p21 和细胞周期蛋白 B1 蛋白在 24 小时时明显过度积累。此外,CA4P 处理显示有丝分裂标志物(有丝分裂蛋白单克隆 - 2 抗体)的表达增加以及细胞核中细胞周期蛋白 B 的过度积累。我们的研究结果表明,CA4P 诱导 WSU - CLL 细胞发生有丝分裂灾难并主要在 M 期停滞,这与 p53 无关,也与 chk1 和 cdc2 磷酸化途径无关。凋亡是一小部分细胞中通过半胱天冬酶 9 激活和 PARP 裂解导致死亡的次要机制。在我们的模型中,细胞死亡的两种机制,即有丝分裂灾难和凋亡,彼此独立。